Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Healthcare Medical Devices
Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Therma Bright Inc > WHAT TO DO NOW
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(903)
•••
Comment by Moemoney42on Mar 19, 2021 1:35pm
146 Views
Post# 32838921

RE:RE:WHAT TO DO NOW

RE:RE:WHAT TO DO NOW
cote101 wrote:
cote101 wrote:
Stop focusing on dates and delays ( we are in Covid situation) and we will be rich because of this Covid situation. The most important thing is that we have a note of 100% / 100% and with this, success is guaranteed and RISK are almost over. BUY ALL YOU CAN NOW or you will pay a lot more later . Me i am done with 600K now Cote101

The approval process will be much faster in Brazil. I would even say that we can foresee sales as soon as the end of April 2021 and I foresee sales of some 2 million tests per month. This could bring the stock price to around $ 4.80 with $ 5 profit per test. North America will follow at the end of May-June 21 with another million tests per month but has $ 10 profit per test this time. This will bring the value of the share to $ 9.60 at the end of June 2021. That is 25 times the current value. What does it take to convince investors to keep their shares and even buy them back at this ridiculous price. Stop day trading and penny flipping and act like a professional investor. Cote101

WOW..  do you really believe your hype/BS?? I'll bet you $1000 none of your predictions come true..! The downside is you probably won't have the $1000 come end of June...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities